Display Settings:

Format

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Curr Opin Obstet Gynecol. 2001 Dec;13(6):595-603.

Major postpartum haemorrhage.

Mousa HA, Walkinshaw S.

University Department of Obstetrics & Gynaecology, Liverpool Women's Hospital, Crown Street, Liverpool, L8 7SS, UK.

Postpartum haemorrhage remains in the top five causes of maternal deaths in both developed and developing countries. Persistent blood loss of more than 1000 ml should prompt predetermined measures to achieve resuscitation and haemostasis. A protocol including guidelines is given and volume replacement is discussed. The range of medical and surgical interventions that may be considered for the modern management of major haemorrhage unresponsive to oxytocin and ergometrine are presented. The review discusses in depth the use of misoprostol, recombinant activated factor VII, the uterine tamponade procedures, artery ligation, and uterine haemostatic suturing techniques. It also evaluates the place of interventional radiology and hysterectomy in modern obstetrics.

PMID: 11707663 [PubMed - indexed for MEDLINE]

Supplemental Content

Patient drug information

  • Misoprostol (Cytotec®)

    Misoprostol is used to prevent ulcers in people who take certain arthritis or pain medicines, including aspirin, that can cause ulcers. It protects the stomach lining and decreases stomach acid secretion.